The Sinopharm Vaccine will be available at EHA Clinic@Jurong. 

You are eligible if you

• have consulted a doctor at EHA Clinic @Jurong about the risks and benefits of using the Sinopharm vaccine
• are above 18 years old 
• are Singaporean, a PR, or hold either a SP, EP, WP or a long term visitor pass.

You are NOT eligible if you

• are a tourist
• on a short term visitor pass

Please note that the Sinopharm COVID-19 vaccine remains unregistered and is not authorised by the Health Sciences Authority (HSA) for use under the Pandemic Special Access Route – it is to be provided only under the SAR framework, and hence will not be covered under the Vaccine Injury Financial Assistance Programme (VIFAP) (https://www.todayonline.com/singapore/covid-19-vaccination-moh-provide-financial-assistance-people-affected-serious-side-effects), meant for our national vaccination programme.

The administration of the Sinopharm vaccine is charged at $55/dose. Two doses are required as part of the vaccination program. 

– Individuals with a history of anaphylaxis to any component of the vaccine should not take it.
– Persons with acute PCR-confirmed COVID-19 should not be vaccinated until after they have recovered from acute illness and the criteria for ending isolation have been met.
– Anyone with a body temperature over 38.5°C should postpone vaccination until they no longer have a fever.

As of 2 December 2020, WHO lists 51 vaccine candidates in clinical trials, and 163 in pre-clinical studies. Vaccines in Phase 3 studies fall into 5 main categories: 

1. mRNA vaccines: e.g. Pfizer-BioNTech, Moderna, Arcturus 
2. virus vectored vaccines: e.g. Astra-Zeneca, Gamaleya, Can-Sino 
3. inactivated virus vaccines: e.g. Sinovac, Bharat 
4. protein subunit vaccines: e.g. Novavax, Sanofi-Pasteur 
5. virus-like particle (VLP) vaccines: e.g. Medicago  

Currently as of 17th of June 2021, Pfizer-BioNTech and  Moderna are part of the National Vaccination Program, and Sinopharm is approved under the Special Access Route (SAR).

More information can be found here: https://www.moh.gov.sg/covid-19/vaccination

The WHO Strategic Advisory Group of Experts  recommends the use of Sinopharm vaccine as 2 doses (0.5 ml) given intramuscularly. WHO recommends an interval of 2–4 weeks between the first and second dose. It is recommended that all vaccinated individuals receive two doses.

If the second dose is administered less than 2 weeks after the first, the dose does not need to be repeated. If administration of the second dose is delayed beyond 4 weeks, it should be given at the earliest possible opportunity.

How do I manage the side effects? Like all vaccines, this vaccine can cause side effects. Most side effects are mild or moderate, and usually get better within a few days. The table below lists some common side effects that have been reported with this vaccine, and how to manage them. 

See a doctor if the side effects persist or get worse, if the fever persists for more than 48 hours or if respiratory symptoms such as cough, runny nose, sore throat, shortness of breath or loss of your sense of taste and smell develops. 

Systemic reactions that affected more than just the injection site can also include:

• diarrhea
• muscle weakness

These symptoms were reported far less than those in the above table, according to trial data.

Very rarely, this vaccine can cause a severe allergic reaction or anaphylaxis. Signs of a severe allergic reaction include difficulty breathing, swelling of your face, throat, eyes or lips, a fast heartbeat, dizziness, weakness and/or a bad rash all over your body. 

Please be advised that there may be potentially more side effects / adverse reactions than which are currently known and published.